Postischemic Long-Term Treatment with Qiangli Tianma Duzhong Capsule Improves Brain Functional Recovery via the Improvement of Hemorrheology and the Inhibition of Platelet Aggregation in a Rat Model of Focal Cerebral Ischemia.

Evid Based Complement Alternat Med 2013 29;2013:795365. Epub 2013 Oct 29.

Department of Pharmacology and Laboratory of Cerebrovascular Pharmacology, College of Pharmaceutical Science, Soochow University, Suzhou 215123, China.

Qiangli Tianma Duzhong capsule (TMDZ), a Chinese herbal drug, is clinically used to improve functional outcome in patients with ischemic stroke in China. This study was conducted to establish whether postischemic long-term treatment with TMDZ could reduce the loss of injured hemisphere and confer the improvements of neurological outcome in chronic survival of rats with 2 h middle cerebral artery occlusion (MCAO)/reperfusion brain injury and its primary mechanisms. We found that TMDZ (44.5, 89, or 178 mg/kg), administered per os 6 h after the onset of ischemia and for 28 consecutive days, significantly improved the behavior deficits, beginning on day 7, and further improved later. TMDZ treatment also markedly reduced the tissue loss of the injured hemisphere and improved histopathology. In the meantime, TMDZ treatment could improve hemorrheology and inhibit platelet aggregation. These results provide the first evidence that post-ischemic long-term treatment with TMDZ confers the improvements of neurological outcome and the loss of injured hemisphere in an animal ischemic stroke model, and its mechanisms might be associated with the improvements of hemorrheology and the inhibition of platelet aggregation.

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/795365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830819PMC
December 2013
31 Reads

Publication Analysis

Top Keywords

injured hemisphere
12
platelet aggregation
12
long-term treatment
12
loss injured
12
inhibition platelet
8
hemorrheology inhibition
8
tmdz treatment
8
ischemic stroke
8
duzhong capsule
8
treatment tmdz
8
improvements neurological
8
neurological outcome
8
postischemic long-term
8
qiangli tianma
8
tianma duzhong
8
tmdz
6
treatment
5
178 mg/kg administered
4
445 178 mg/kg
4
tmdz 445
4

References

(Supplied by CrossRef)

Chinese Pharmaceutical Journal 2002

Similar Publications